PIPE-505
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PIPE-505, covering 2025-03-04 to 2025-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss [Phase 1, Phase 2]